Meningococcal Vaccine Market was valued at USD 5.2 Billion in 2022 and is projected to reach USD 9.1 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030.
However, from 2023 to 2033, the demand for meningococcal vaccines is expected to experience substantial shifts, influenced by evolving disease patterns, vaccine availability, and public health policies. As outbreaks of meningococcal disease become less frequent due to widespread vaccination campaigns, the demand for meningococcal vaccines is likely to stabilize in some regions while growing in others, especially in low-income countries where vaccination coverage remains low.
The introduction of new vaccines that target additional strains of Neisseria meningitidis will also play a key role in shaping the market outlook. Governments and healthcare organizations may prioritize broader vaccine coverage, creating a demand for innovative solutions that offer protection against a wider range of pathogens. Moreover, global trends such as increased travel, immigration, and the emergence of new variants may influence market dynamics and vaccine demand.
Get an In-Depth Research Analysis of the Global Meningococcal Vaccine Market Size And Forecast [2025-2032]
The meningococcal vaccine market has experienced significant growth from 2018 to 2022, driven by an increasing number of cases of meningitis worldwide and the global awareness of the need for prevention. The market was largely dominated by vaccines aimed at protecting against the five primary types of Neisseria meningitidis (A, B, C, W, and Y). Pharmaceutical companies invested heavily in research and development during this period, leading to advanced vaccine formulations, more widespread vaccination programs, and government-backed immunization campaigns.
During the 2018-2022 period, key players such as GlaxoSmithKline, Pfizer, and Sanofi produced vaccines that helped increase the global vaccination rates, especially in regions with high incidences of meningococcal disease. The market growth was fueled by a heightened awareness among parents and healthcare professionals about the risks of meningitis and the importance of vaccination. As a result, countries with national immunization schedules began to integrate meningococcal vaccines as part of their routine vaccinations for adolescents, contributing to market expansion.
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Meningococcal Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Meningococcal Vaccine Market
Pneumonia
Meningitis
Bacteremia
Others (Arthritis
Conjunctivitis
Urethritis)
Based on Types the Market is categorized into Below types that held the largest Meningococcal Vaccine market share In 2023.
Quadrivalent
Bivalent
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Meningococcal Vaccine Market Research Analysis
1. Introduction of the Global Meningococcal Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Meningococcal Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Meningococcal Vaccine Market, By Type
6. Global Meningococcal Vaccine Market, By Application
7. Global Meningococcal Vaccine Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Meningococcal Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/